A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient Preference

Program Overview

This multi-activity CME curriculum is designed to be directed to your needs. The initial activity is interactive and fast-paced. It allows you to test your knowledge and practice through a series of case vignettes, to compare yourself to your peers and find out what the experts have to say about rheumatoid arthritis (RA). Once you have completed the activity, you will be directed to other activities in RA that may be of interest.

Credit Expired

Target Audience

Physicians, nurse practitioners, and physician assistants who specialize in rheumatology and internal medicine.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Incorporate guideline-recommended disease activity measures into clinical practice
Select individualized treatments for patients with rheumatoid arthritis (RA) that maximize the opportunity to achieve remission and avoid relapse while minimizing toxicity
Employ a strong patient-provider collaborative approach to managing patients with RA that includes patient education, engagement, and shared decision making

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

William J. Koopman Endowed Professor in Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders
Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Birmingham, AL

Featured RMEI CE Activities – Earn CE Credit(s)

A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient Preference

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe